Bioton's LB03002 comparable to rhGH

Bioton (Warsaw, Poland) said all 3 dosages of weekly LB03002 resulted in sustained growth that was comparable to daily rhGH in a Phase II/III trial in 51 previously untreated children with growth hormone deficiency (GHD). LB03002, a sustained-release recombinant human growth hormone, is in Phase III testing, and the company expects to submit an MAA to EMEA in 2009. ...